Duzallo

Active Ingredient(s): Lesinurad + Allopurinol
FDA Approved: * August 18, 2017
Pharm Company: * ARDEA BIOSCIENCES INC
Category: Gout

Lesinurad/allopurinol (trade name Duzallo) is a fixed-dose combination drug for the treatment of gout. It contains 200 mg of lesinurad and 300 mg of allopurinol. In August 2017, the US Food and Drug Administration approved it for the treatment of hyperuricemia associated with gout in patients for whom target serum uric acid levels have not been achieved with allopurinol alone.[1] It was approved for medical use in the European Union in August 2018.[2] In Febr... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Duzallo Oral Tablet, Film Coated
NDC: 70785-021
Labeler:
Ironwood Pharmaceuticals, Inc.
Duzallo Oral Tablet, Film Coated
NDC: 70785-022
Labeler:
Ironwood Pharmaceuticals, Inc.